Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Classificação em ações #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Preço da ação
$0.0202
Última sincronização: 2024-11-19
Valor de mercado
$44.67K
Variação (1 dia)
-0.49%
Variação (1 ano)
0.00%
País
IL
Negociar Notable Labs, Ltd. (NTBL)

Categoria

Lucros da Notable Labs, Ltd. (NTBL)
Lucros em Jun 2024 TTM: $-8.99M
De acordo com os últimos relatórios financeiros da Notable Labs, Ltd., os ganhos atuais da empresa são de $-8.99M. Em 2022, a empresa teve ganhos de $-14.41M, um aumento em relação a aos ganhos de 2021, que foram de $-16.05M. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Notable Labs, Ltd. de 2015 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
2026 (TTM) $-8.99M -20.23%
2023 $-11.26M -21.82%
2022 $-14.41M -10.25%
2021 $-16.05M -33.74%
2020 $-24.23M 24.90%
2019 $-19.40M -5.19%
2018 $-20.46M 101.80%
2017 $-10.14M -36.65%
2016 $-16.00M 7.48%
2015 $-14.89M 0.00%
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
$5.27B -58,807.85%
US
$1.95B -21,810.07%
NL
- -
CH
- -
KR
$3.01B -33,552.61%
BE